Mustang Bio, Inc.
MBIO
$1.54
-$0.11-6.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.18M | 3.93M | 4.14M | 6.54M | 7.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.57M | 7.58M | 12.55M | 21.44M | 31.64M |
| Operating Income | -2.57M | -7.58M | -12.55M | -21.44M | -31.64M |
| Income Before Tax | -3.28M | -10.71M | -15.75M | -23.42M | -32.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.28 | -10.71 | -15.75 | -23.42 | -32.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.28M | -10.71M | -15.75M | -23.42M | -32.06M |
| EBIT | -2.57M | -7.58M | -12.55M | -21.44M | -31.64M |
| EBITDA | -2.43M | -7.16M | -11.88M | -20.53M | -30.50M |
| EPS Basic | -3.10 | -21.27 | -46.03 | -88.11 | -147.74 |
| Normalized Basic EPS | -1.29 | -8.94 | -24.42 | -52.35 | -94.78 |
| EPS Diluted | -3.10 | -21.27 | -46.03 | -88.11 | -147.74 |
| Normalized Diluted EPS | -1.29 | -8.94 | -24.42 | -52.35 | -94.78 |
| Average Basic Shares Outstanding | 8.63M | 5.06M | 2.40M | 1.59M | 1.02M |
| Average Diluted Shares Outstanding | 8.63M | 5.06M | 2.40M | 1.59M | 1.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |